BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19686049)

  • 1. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.
    Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA
    Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher expression of transcription targets and components of the nuclear factor-kappaB pathway is a distinctive feature of umbilical cord blood CD34+ precursors.
    Panepucci RA; Calado RT; Rocha V; Proto-Siqueira R; Silva WA; Zago MA
    Stem Cells; 2007 Jan; 25(1):189-96. PubMed ID: 16973832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells.
    He X; Gonzalez V; Tsang A; Thompson J; Tsang TC; Harris DT
    Stem Cells Dev; 2005 Apr; 14(2):188-98. PubMed ID: 15910245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells.
    Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J; Jaatinen T
    Stem Cells Dev; 2006 Dec; 15(6):839-51. PubMed ID: 17253947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
    Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
    Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
    Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
    Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Expansion of SALL4-Transduced Umbilical Cord Blood Derived CD133+Hematopoietic Stem Cells.
    Mossahebi-Mohammadi M; Atashi A; Kaviani S; Soleimani M
    Acta Med Iran; 2017 May; 55(5):290-296. PubMed ID: 28724268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiles in umbilical cord blood cell lineages.
    Merkerova M; Vasikova A; Belickova M; Bruchova H
    Stem Cells Dev; 2010 Jan; 19(1):17-26. PubMed ID: 19435428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of immunophenotype of hematopoietic stem/progenitor cells in human umbilical cord blood with flow cytometry and its significance].
    Guo R; Ma B; Zou D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):426-8. PubMed ID: 11718095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia.
    Toren A; Bielorai B; Jacob-Hirsch J; Fisher T; Kreiser D; Moran O; Zeligson S; Givol D; Yitzhaky A; Itskovitz-Eldor J; Kventsel I; Rosenthal E; Amariglio N; Rechavi G
    Stem Cells; 2005 Sep; 23(8):1142-53. PubMed ID: 16140871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global gene expression profile of human cord blood-derived CD133+ cells.
    Jaatinen T; Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J
    Stem Cells; 2006 Mar; 24(3):631-41. PubMed ID: 16210406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
    Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
    Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.